People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phoreus Biotechnology, Inc. | — | Biotechnology | Series A | $5.4M | $1.2M | 2018 |
Matthew Tomich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Tomich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Schaefer | 1 | 2 |
| Douglas Shane | 1 | 1 |
| Bill Ashley | 1 | 1 |
| Steve Schram | 1 | 1 |
| Rajeet Pannu | 1 | 1 |
| Michael Coe | 1 | 1 |
| Lynn Rundle | 1 | 1 |
| Bradley Holliday | 1 | 1 |
| Nathan Singh | 1 | 1 |
| Randall Tosh | 1 | 1 |
| Christopher Brandt | 1 | 1 |
| Scott Nagley | 1 | 1 |
| Xiomara Sinisterra-Hunter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.